Adrenergic Activation, Fuel Substrate Availability, and Insulin Resistance in Patients With Congestive Heart Failure
- 5 August 2013
- journal article
- Published by Elsevier in JACC: Heart Failure
- Vol. 1 (4) , 331-337
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failureEuropean Heart Journal, 2010
- The Adrenergic-Fatty Acid Load in Heart FailureJACC, 2009
- Mechanisms of Disease: detrimental adrenergic signaling in acute decompensated heart failureNature Clinical Practice Cardiovascular Medicine, 2008
- Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart FailureJournal of Cardiac Failure, 2006
- Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart FailureCirculation, 2006
- Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivoAtherosclerosis, 2004
- Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose MetabolismDiabetes Care, 2003
- Myocardial Fatty Acid MetabolismHypertension, 2003
- Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart FailureJACC, 1997
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974